生物膜
抗菌剂
肽
抗生素
化学
抗菌肽
人类健康
选择性
药物发现
组合化学
药品
药物开发
计算生物学
病菌
微生物学
细菌
人类病原体
生物
候选药物
药理学
纳米技术
生物化学
抗菌剂
抗生素耐药性
毒性
作者
Parweenuch Santaweesuk,Worada Khumbungkha,Thararin Ngamsiri,Chonlatip Pipattanaboon,Supranee Phanthanawiboon,Watshara Shoombuatong,Sakawrat Kanthawong
出处
期刊:Biofouling
[Taylor & Francis]
日期:2026-01-02
卷期号:42 (1): 85-98
标识
DOI:10.1080/08927014.2025.2604263
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) poses a major global health threat and is recognized by the World Health Organization as a high-priority pathogen for new drug development. MRSA's ability to form biofilms further complicates treatment and enhances antibiotic resistance. Antimicrobial peptides (AMPs) present a promising alternative to conventional antibiotics, however, their discovery remains labor-intensive. This study utilized computational and experimental approaches to evaluate the physicochemical properties, anti-MRSA activity against 10 clinical isolates, bacterial selectivity, cytotoxicity, and antibiofilm effects of AMPs. Temporin-PF (TPF) peptide was identified as a leading candidate and modified to generate TPF-M1, achieving an improved anti-MRSA score of 600.0. TPF-M1 exhibited enhanced killing activity and selectivity against MRSA with low toxicity toward human cells. At 20 µM, TPF-M1 effectively reduced MRSA biofilm viability using the transferable solid-phase pin lid method and disrupted the biofilm structure. These findings underscore the potential of AI-guided AMP development for anti-MRSA therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI